A One Health Horizon Scanning study led by CABI gathered insights from more than 400 stakeholders across governments, research institutions and organisations. The study found the main problem is poor information flow between human, animal and environmental sectors, not simply a lack of data.
Respondents put integrated surveillance at the top of their priorities. WHO Africa said surveillance must reach all levels of the health system, including peripheral services. Africa CDC noted that outbreaks begin and end in the community, so community health workers should be trained, numerous and well integrated.
Examples from Nigeria show patients often arrive late and diagnostics must be usable where patients are seen. The brief also warns that climate and environmental problems and limited financing make surveillance harder.
Difficult words
- stakeholder — person or organisation with an intereststakeholders
- surveillance — ongoing observation and checking of health
- peripheral — at the edge or outer parts
- integrate — to join parts so they work togetherintegrated
- finance — to provide money for a project or activityfinancing
- environmental — relating to the natural world and surroundings
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- Do you think community health workers are important where you live? Why or why not?
- What makes surveillance harder, according to the article?
- How could better information flow help health services in your area?
Related articles
Traditional African Diet Reduces Inflammation
A trial in Tanzania found that a traditional plant-based African diet lowered inflammation within two weeks, while a short-term Western diet increased inflammation and weakened immune responses. The results matter for rising non-communicable diseases in Sub-Saharan Africa.
Experimental vaccine gives lasting protection in mice against CCHF
A new mouse study reports an experimental vaccine that produced rapid protection and antibodies that lasted up to 18 months. Researchers say a booster strengthened and extended immune responses and plan manufacturing steps before human trials.
